Staphylococcus Aureus
/api/v1/drug/staphylococcus-aureusIndications
Sourced from openFDA- Aids in temporary relief of headache, runny nose, chills, minor cough, fatigue, and mild abdominal discomfort.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.ICD-10: R05.9, R51.9
Dosage & administration
Sourced from openFDADIRECTIONS: Adults: 2 to 3 sprays orally, three times daily. Children under twelve one half adult dosage. Do not take within 15 minutes of consuming food, beverage or brushing teeth. Consult a physician for use in children under 12 years of age.
Warnings & precautions
Sourced from openFDAProfessional Use Only If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening
Literature
Recent PubMed references pinned to Staphylococcus Aureus as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Mortality associated with healthcare-associated Staphylococcus aureus bacteraemia in Aotearoa New Zealand.The New Zealand medical journal · 2026 · Roberts SA, Waddell D, Atkins S, et al.PMID 42275656DOI 10.26635/6965.7321
- Unveiling the bactericidal effects of extracts and phytocompounds from Eichhornia crassipes (Mart.) Solms against methicillin-resistant Staphylococcus aureus (MRSA): An in vitro and in silico approach.PloS one · 2026 · Rahman MM, Simu SS, Shahir NF, et al.PMID 42275453DOI 10.1371/journal.pone.0349750
- In Vivo Assessment of Antimicrobial Potential of Synthetic ANLP-V3 Peptide for the Treatment of Mastitis in a Mouse Model.Current microbiology · 2026 · Kaur J, Lather A, Jangir BL, et al.PMID 42268315DOI 10.1007/s00284-026-04993-0
- Clinical Rel mutations that increase basal (p)ppGpp promote conjugal transfer of staphylococcal resistance plasmids.Microbiology (Reading, England) · 2026 · Deventer AT, Sutherland A, Biernacka D, et al.PMID 42262838DOI 10.1099/mic.0.001724
- Urogenital infections select for reduced ability to grow in a low-iron environment and reduced blood survival for Staphylococcus aureus.Microbiology (Reading, England) · 2026 · Kearney KP, Ledger EVK, Recker M, et al.PMID 42258294DOI 10.1099/mic.0.001691
- [Phenotype and Genotype of Staphylococcus aureus Isolated from the Nostrils of Elderly Adults in the Valparaíso Region, Chile, from June 2019 to January 2020].Revista medica de Chile · 2026 · Aravena C, Caneo R, Lecanda Ossandón J, et al.PMID 42257656DOI 10.4067/s0034-98872026000300301
- Bioinformatics Approaches for Functional and Structural Annotation and Molecular Docking Study of a Hypothetical Protein From Staphylococcus aureus.BioMed research international · 2026 · Chowdhury MH, Morshed MR, Alam MJ, et al.PMID 42252783DOI 10.1155/bmri/1109584
- Antimicrobial and antibiofilm effects of Lactobacillus cell-free supernatants against standard and antibiotic-resistant Pseudomonas aeruginosa and Staphylococcus aureus.Archives of microbiology · 2026 · Jasour SY, Mohammadhosseinzadeh F, Arefian E, et al.PMID 42250125DOI 10.1007/s00203-026-04836-3
Clinical trials
The 10 most recently updated of 532 ClinicalTrials.gov registrations naming Staphylococcus Aureus as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Staph Intervention for Effective Local DefenseCompleted · Phase 4 · Interventional · 78 enrolled · Johns Hopkins Bloomberg School of Public HealthNCT06210594updated 2026-06-12
- Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic SinusitisNot yet recruiting · Early phase 1 · Interventional · 108 enrolled · The First Affiliated Hospital of Xinxiang Medical CollegeNCT07635433updated 2026-06-09
- Honey as an Adjunctive Wound Care Modality for Deep Neck Space AbscessCompleted · Interventional · 36 enrolled · Gadjah Mada UniversityNCT06562257updated 2026-06-08
- Bacterial Decolonization Within DyadsCompleted · Interventional · 1 enrolled · Duke UniversityNCT06541145updated 2026-06-03
- Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract IllnessCompleted · Phase 2 · Interventional · 822 enrolled · University of ArizonaNCT02148796updated 2026-06-02
- Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus BacteremiaRecruiting · Phase 2 · Interventional · 60 enrolled · Todd C. Lee MD MPH FIDSANCT04886284updated 2026-05-27
- Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus BacteremiaRecruiting · Phase 4 · Interventional · 300 enrolled · Todd C. Lee MD MPH FIDSANCT06637332updated 2026-05-26
- Evaluation of the Antibiofilmogramme® Test During Diabetic Foot InfectionsCompleted · Interventional · 33 enrolled · Centre Hospitalier Universitaire de NīmesNCT02378493updated 2026-05-15
- Impact of a Daily Application of an Omega-3 Monoglycerides Based Serum and Cream on the Skin MicrobiotaNot yet recruiting · Interventional · 10 enrolled · SCF PharmaNCT07583121updated 2026-05-13
- Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)Completed · Interventional · 2,542 enrolled · University of AlbertaNCT06338176updated 2026-05-12
Frequently asked questions
- What is Staphylococcus Aureus used for?
- According to FDA labeling, Staphylococcus Aureus carries indications including: Aids in temporary relief of headache, runny nose, chills, minor cough, fatigue, and mild abdominal discomfort.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
staphylococcus-aureus is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.